The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells

35Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: As a well-characterized key player in various signal transduction networks, extracellular-signal-regulated kinase (ERK1/2) has been widely implicated in the development of many malignancies. We previously found that Leucine-rich repeat containing 4 (LRRC4) was a tumor suppressor and a negative regulator of the ERK/MAPK pathway in glioma tumorigenesis. However, the precise molecular role of LRRC4 in ERK signal transmission is unclear. Methods: The interaction between LRRC4 and ERK1/2 was assessed by co-immunoprecipitation and GST pull-down assays in vivo and in vitro. We also investigated the interaction of LRRC4 and ERK1/2 and the role of the D domain in ERK activation in glioma cells. Results: Here, we showed that LRRC4 and ERK1/2 interact via the D domain and CD domain, respectively. Following EGF stimuli, the D domain of LRRC4 anchors ERK1/2 in the cytoplasm and abrogates ERK1/2 activation and nuclear translocation. In glioblastoma cells, ectopic LRRC4 expression competitively inhibited the interaction of endogenous mitogen-activated protein kinase (MEK) and ERK1/2. Mutation of the D domain decreased the LRRC4-mediated inhibition of MAPK signaling and its anti-proliferation and anti-invasion roles. Conclusions: Our results demonstrated that the D domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells. These findings identify a new mechanism underlying glioblastoma progression and suggest a novel therapeutic strategy by restoring the activity of LRRC4 to decrease MAPK cascade activation.

References Powered by Scopus

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

6412Citations
N/AReaders
Get full text

Pathological roles of MAPK signaling pathways in human diseases

2006Citations
N/AReaders
Get full text

Hyperactive Ras in developmental disorders and cancer

1331Citations
N/AReaders
Get full text

Cited by Powered by Scopus

TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway

205Citations
N/AReaders
Get full text

MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway

150Citations
N/AReaders
Get full text

Circular RNAs: Functions and Prospects in Glioma

49Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, Z., Guo, Q., Wang, R., Xu, G., Li, P., Sun, Y., … Wu, M. (2016). The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells. Journal of Hematology and Oncology, 9(1). https://doi.org/10.1186/s13045-016-0355-1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

79%

Professor / Associate Prof. 1

7%

Lecturer / Post doc 1

7%

Researcher 1

7%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

33%

Medicine and Dentistry 4

27%

Neuroscience 3

20%

Agricultural and Biological Sciences 3

20%

Save time finding and organizing research with Mendeley

Sign up for free